The emergence of P. falciparum parasites with deletions in the pfhrp2 and pfhrp3 genes in most malaria-endemic regions poses a significant biological threat to malaria control. These parasites are undetectable ...
In April this year, Benin’s streets echoed with the calls of town criers, announcing the launch of the malaria vaccination campaign for children under five. The message from the Ministry ...
Ghana's implementation of the RTS,S malaria vaccine in 2019 has been evaluated in a retrospective study conducted in early 2024. Using an adapted WHO checklist, researchers assessed various aspects of ...
The Health and Justice team at UKHSA are running two webinars to support the publication of the Multi-agency plan for incidents and outbreaks of communicable diseases in secure settings in ...
Background School-age children in sub-Saharan Africa suffer an underappreciated burden of malaria which threatens their health and education. To address this problem, we compared the efficacy of two school-based chemoprevention ...
To build the network, CEPI and Gates are seeking experts to offer training and mentorship to researchers and professionals in Global South institutions on epidemic and pandemic data analytics and infectious disease modelling Read more
The AESI list for mpox vaccines is derived from mpox disease pathogenesis and vaccine platforms, as well as considerations for manifestations in special populations (children, pregnant women, and immunocompromised hosts) Read more
This meeting was attended by 60+ public health and animal health experts, researchers, epidemiologists, modelers, regulators, and funders (from across Africa, the Middle East and Europe) to discuss advances and gaps in epidemiology and modelling for human RVF vaccine development. Read more
This webinar gives an overview of what is known about RVF epidemiology, where knowledge gaps impede the development of RVF vaccines for human use, and launches a Call for Proposals by CEPI to address these gaps. Read more
The Companion Guide, developed by the SPEAC Project, includes ICD9/10-CM, MedDRA & SNOMEDCT codes, background rates, risk factors, guidance, and tools including a data abstraction & interpretation form for Acute Aseptic Arthritis Read more
The CEPI CLN implemented key steps in the transfer and monitoring of the developed immunological SARS-CoV-2 assays. This article provides a brief elaboration on the specific measures and procedures implemented to standardize the transfer of assays across the network. Read more
Resources
SPEAC is a CEPI and Brighton Collaboration project. SPEAC provides vaccine safety tools, resources, and expertise throughout the vaccine development process to enhance safety and build confidence in vaccines.
Monitoring Vaccine Performance against SARS CoV-2 Variants
The IVAC COVID-19 Vaccine Effectiveness Project (a CEPI- funded global systematic review which also includes neutralization capacity) outputs are publicly available on VIEWhub to assist all policy makers
International Pandemic Preparedness Secretariat
The IPPS serves to join up relevant states, the private sector, and global health institutions in support of the 100 Days Mission, across vaccines, therapeutics, and diagnostics. It performs a global annual progress review related to the 100 DM which feeds into implementation reports.
Vaccine Development
Process Maps
The UK Vaccine R&D Network has developed vaccine development maps to show key stages in human and veterinary vaccines development up to Phase III clinical trials. These process maps and associated case studies provide support in understanding key stages in vaccine development and where bottlenecks could cause delays.
